巴西与美国肝硬化患者微生物组、饮食与住院的交互作用
该研究比较了巴西与美国肝硬化患者的饮食、肠道微生物群及90天住院情况,发现巴西患者摄入更多谷物和酸奶,微生物多样性更高,有益菌群更丰富,住院率更低;饮食与来源可能影响肝硬化结局。
要点
- 巴西肝硬化患者谷物和酸奶摄入更高,微生物多样性更高。
- 巴西患者有益菌群如瘤胃球菌科和普雷沃菌科更高,致病菌更低。
- 美国患者住院率更高,巴西来源与巧克力摄入与更低住院相关。
核心结论
- 巴西肝硬化患者饮食富含谷物和酸奶,与更高微生物多样性和有益菌群相关,可能有助于降低住院率。
研究设计与样本
- 比较美国与巴西的健康对照和代偿/失代偿期肝硬化门诊患者,进行饮食回顾和16S rRNA测序,随访90天住院情况。
主要发现
- 巴西患者谷物、大米和酸奶摄入更高,随着疾病进展谷物、大米/豆类、咖啡和巧克力摄入减少。
- 巴西患者微生物多样性更高,高多样性 related to 巴西来源(P < .0001)、年龄和谷物摄入(P = .05),高MELD(P = .009)和腹水(P = .05)则相反。
- 巴西患者有益菌群(Ruminococcaceae、Christensenellacae、Prevotellaceae)更高,致病菌(Porphyromonadaceae、Sutterellaceae、Enterobacteriaceae)更低。
- 美国患者住院更多(P = .002);回归中MELD(P = .001)和腹水(P = .001)与更高住院相关,巧克力(P = .03)和巴西来源(P = .001)与更低住院相关。
临床怎么用
- 对于肝硬化患者,可考虑评估饮食模式,鼓励摄入谷物和酸奶等可能有益微生物群的饮食。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Gut microbiota are affected by diet, country, and affect outcomes in cirrhosis. Western diets are associated with dysbiosis. Comparisons with other diets is needed. We aimed to compare cirrhosis patients from the United States with cirrhosis patients from Brazil with respect to diet, microbiota, and impact on hospitalizations. METHODS: Healthy controls and compensated/decompensated outpatients with cirrhosis from the United States and Brazil underwent dietary recall and stool for 16S ribosomal RNA sequencing. Demographics and medications/cirrhosis details were compared within and between countries. Patients with cirrhosis were followed up for 90-day hospitalizations. Regression for Shannon diversity was performed within cirrhosis. Regression for hospitalizations adjusting for clinical and microbial variables was performed. RESULTS: Model for end-stage liver disease (MELD), diabetes, ascites, and albumin were similar, but more Americans were men, had higher hepatic encephalopathy and alcohol/hepatitis C etiology, with lower nonalcoholic fatty liver disease than Brazilians. Brazilians had higher cereal, rice, and yogurt intake vs the United States. As disease progressed, cereals, rice/beans, coffee, and chocolate consumption was reduced. Microbial diversity was higher in Brazilians. Within cirrhosis, high diversity was related to Brazilian origin (P < .0001), age, and cereal intake (P = .05), while high MELD scores (P = .009) and ascites (P = .05) did the reverse. Regardless of stage, beneficial taxa and taxa associated with grant and yogurt intake were higher (Ruminococcaceae, Christensenellacae, and Prevotellaceae), while pathobionts (Porphyromonadaceae, Sutterellaceae, and Enterobacteriaceae) were lower in Brazilians. More Americans were hospitalized vs Brazilians (P = .002). On regression, MELD (P = .001) and ascites (P = .001) were associated with higher hospitalizations, while chocolate (P = .03) and Brazilian origin (P = .001) were associated with lower hospitalizations with/without microbiota inclusion. CONCLUSIONS: Brazilian cirrhotic patients follow a diet richer in cereals and yogurt, which is associated with higher microbial diversity and beneficial microbiota and could contribute toward lower hospitalizations compared with a Western-diet-consuming American cohort.
引用
- Álvares-da-Silva MR, Oliveira CP, Fagan A, et al. Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021. PMID: 33813071. doi:10.1016/j.cgh.2021.03.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。